Morocco vs Nepal: HIV/AIDS deaths averted by antiretroviral therapy
Morocco
1,213 deaths
in 2024
Nepal
1,348 deaths
in 2024
Morocco rank
70th
Nepal rank
69th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Morocco
- Nepal
How they compare
Nepal currently reports 1,348 deaths against 1,213 deaths in Morocco, a difference of 135 deaths.
That makes Nepal's figure about 1.1 times Morocco's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Nepal ahead.
Morocco ranks 70th and Nepal ranks 69th of 157 countries.
Across the 4 decades both report, Morocco averaged higher in 1 and Nepal in 2.
Head to head by decade
| Decade | Morocco | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 183.06 deaths | 175.89 deaths | 7.17 deaths | Morocco |
| 2010s | 725.97 deaths | 1,151 deaths | 424.53 deaths | Nepal |
| 2020s | 1,101 deaths | 1,335 deaths | 234.32 deaths | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Morocco or Nepal?
- Nepal, at 1,348 deaths against 1,213 deaths in Morocco as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Morocco and Nepal?
- 135 deaths, with Nepal ahead.
- How many years of comparable data are there for Morocco and Nepal?
- 35 years are reported by both, from 1990 to 2024.
- How do Morocco and Nepal rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Morocco ranks 70th and Nepal ranks 69th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.